Hello Share Folk. I’m going to the hospital today to see about my prostate gland. I started the routine tests a few years ago and have been under the eye of a brilliant consultant ever since. There’s a lot of debate of whether we should have these tests done, as it causes a lot of anxiety and their reliability is not always that great. On the whole I would suggest you do have them done, if you’re of a certain age. But what do I know?
The visit to hospital confirms my view, though, that there one thing more important than the health of our shares – and that’s the health of us.
Your shares can drop like a lead-studded anvil down a coal shaft, but if we have good health, collapsing stocks are, in comparison, not in the least bit disturbing.
You can combine the two concerns of course by buying shares in companies, which push forward the frontiers of medical science. You may recall that I’ve invested big time in three life science firms – Feedback (FDBK) Avacta (AVCT) and Advanced Oncotherapy (AVO).
Now at first all three stocks shot ahead. But in recent months there has been a bit of decay going on.
This is not unexpected. Whenever you get a penny share, which looks really promising, there is an army of chancers out there who will take a punt just because the stock is rising like a discarded champagne cork from a submarine.
But when the momentum – usually set off by a single piece of good news for the company – winds down, the same army of opportunists sell again. This dumping continues until the next piece of good news.
In the case of all three aforementioned shares, the future outlook is no less rosier than when I first bout their prospects to your attention.
So I expect good news to keep spewing forth as the months, and indeed years, roll by. Then the army of chancers will turn up again and the share prices will hit mew highs once more. (Though I cannot be certain).
But I’m an optimist, as you know, so you must make up your own mind.
See you in the Punter’s Return tonight?
– See more at: http://www.shareprophets.com/views/16395/my-first-hand-check-on-medical-opportunities-as-i-end-up-in-hospital-ref-feedback-avacter-advanced-oncatherapy#sthash.ZYla6RsZ.dpuf